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ABSTRACT
Hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) strains are no longer limited to
acute-care hospitals but have now spread to other healthcare settings such as long-term-care facilities
(LTCFs), in most of which they are endemic. In Europe, few studies have addressed the MRSA situation
in LTCFs. A cross-sectional study to determine MRSA prevalence and factors associated with S. aureus
carriage in community LTCF residents is reported here. Nasal and decubitus ulcer cultures were
performed for residents of nine community LTCFs. Residents were classified as MRSA carriers,
methicillin-susceptible S. aureus carriers and non-carriers. Overall, 1377 nasal swabs and 82 decubitus
ulcer cultures were performed. MRSA was isolated from 15.5% and 59.0% of the former and latter,
respectively. The prevalence of MRSA colonization was 16.8% (95% CI 14.9–18.8), varying from 6.7% to
35.8% (p <0.001) among LTCFs. Several independent variables were related to MRSA colonization. It is
noteworthy that residents in an LTCF with fewer than 150 beds had at least a two-fold higher probability
of being MRSA carriers. Modifiable factors were medical devices, decubitus ulcers and previous
antibiotic treatment. An age of 85 years or older, a Charlson index ‡2 and transfer from an acute-care
facility were non-modifiable factors also related to MRSA colonization. A high MRSA prevalence among
residents in community LTCFs in Spain, with great variability among facilities, was found. The factors
identified as being associated with MRSA colonization could be prevented by the implementation of
several measures. Control strategies need to be coordinated between LTCFs and acute-care hospitals.
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INTRODUCTION
The introduction and successful dissemination of
methicillin-resistant Staphylococcus aureus (MRSA)
in acute-care hospitals in Spain was reported two
decades ago [1,2], and it has become the major
problem related to multiresistant microorganisms
in the healthcare system. Furthermore, MRSA
strains have spread into facilities related to the
healthcare setting, such as long-term-care facilities
(LTCFs), and are endemic in the majority of them
[3,4]. Control measures to limit MRSA spread in
LTCFs are controversial [5]. Most studies on the
prevalence of MRSA colonization in LTCFs have
been performed inVeterans’ Affairs facilities in the
USA; however, the epidemiology of MRSA in
community LTCFs should be differentiated from
those facilities [6]. In Europe, some studies have
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recently evaluated the prevalence of MRSA colo-
nization in these facilities [7–10]. In Spain, only a
few studies have addressed the interaction of
MRSA strains between hospitals and other health-
care facilities [11–14]. An interesting finding is that
patients with S. aureus bloodstream infection diag-
nosed at hospital admission following referral
from an LTCF were associated with the presence
of methicillin resistance [14]. Patients in whom
MRSA carriage acquired during a previous hospi-
tal admission or stay in a LTCFwas persistentwere
found to be at high risk of MRSA infection,
although a low prevalence of these infections has
been reported inLTCF residents [15,16]. Transfer of
patients from acute-care hospitals to LTCFs is often
delayed because of MRSA carriage. To determine
the extent of this situation, a cross-sectional study
was conducted in a large number of residents in
community LTCFs for the elderly. The aimswere to
determine the prevalence of MRSA colonization
and to define factors associated with S. aureus
carriage in this population.
MATERIALS AND METHODS
Study design
This was a cross-sectional prevalence survey.
Study population and characteristics of community LTCFs
The study was performed in November 2005, in residents of
community LTCFs for the elderly, located in two communities
in Spain (Catalonia and the Balearic Islands).
Nine LTCFs with a total of 1586 beds (median 120; range
72–552 beds) were included in the study. Five of these are
allocated to the geographical area of influence of a 900-bed
acute-care hospital (Hospital Universitari de Bellvitge), three
to that of a 490-bed hospital (Corporacio´ Sanita`ria Parc Taulı´)
and one to that of an 800-bed acute-care hospital (Hospital
Universitari Son Dureta). These facilities provide care for
elderly permanent residents who may be disabled or infirm.
All of these facilities have their own medical services, and
most include a dementia ward. Residents are accommodated
in rooms with one, two or three beds.
These LTCFs do not use active surveillance cultures to
detect MRSA carriage, and decolonization procedures are not
routinely performed. All facilities take standard precautions
for patient care, and contact precautionary measures are
occasionally applied for those patients colonized or infected
by MRSA. A common policy of all the facilities is that known
MRSA carriers are not denied admission.
Data collected
Medical charts were reviewed for basic clinical and epidemi-
ological information. The following data were obtained for all
residents: age, sex, facility and date of admission, underlying
diseases (Charlson index) [17], functional status (Barthel
index) [18], prior MRSA isolation, presence of decubitus
ulcers, previous antibiotic treatment in the last 3 months, use
of invasive devices (peripheral venous catheter, nasogastric
tube and urinary catheter) in the last 7 days, and the presence
of current infections.
Microbiological methods
To assess MRSA colonization, samples for cultures were
obtained from anterior nares and third-degree or higher-
degree decubitus ulcers, when applicable. These areas were
swabbed with sterile cotton-tipped applicator sticks, which
were immediately placed into Stuart transport medium.
Nasal and decubitus ulcer swabs were first plated onto
coagulase–mannitol agar plates and selective MRSA agar
medium (MRSA Select; Bio-Rad Laboratories, Madrid,
Spain). Swabs were then inoculated into staphylococcal
enrichment broth composed of brain–heart infusion plus
7% NaCl. After 24 h of incubation at 35C, the broth was
subcultured onto coagulase–mannitol and MRSA Select
plates. All plates were incubated for 48 h and inspected
daily. Suspected S. aureus colonies were identified by the
latex agglutination test (Pastorex Staph-plus; Bio-Rad
Laboratories) and DNase production (DNase Test Agar;
Biomedics, Madrid, Spain). Methicillin resistance was deter-
mined by the cefoxitin disk diffusion method following CLSI
recommendations. Testing for antimicrobial susceptibility to
penicillin, oxacillin, cefoxitin, erythromycin, clindamycin,
gentamicin, tobramicin, rifampin, tetracycline, trimetho-
prim–sulphamethoxazole, chloramphenicol, ciprofloxacin,
vancomycin, teicoplanin, mupirocine, fusidic acid, quinupri-
stin–dalfopristin and linezolid was performed by the disk
diffusion method. [19].
Statistical analysis
For the purpose of this study and on the basis of the results,
residents were classified as MRSA carriers, methicillin-sus-
ceptible S. aureus (MSSA) carriers and non-carriers. Following
the methodology suggested by Harris et al. [20], two separate
analyses were performed to compare, first, MSSA carriers
with non-carriers, and second, MRSA carriers with non-
carriers. Results were interpreted as follows: significant
variables in the former analysis were considered to represent
unique factors associated with MSSA colonization, and those
in the second were considered to be factors associated with
MRSA colonization. Variables with statistical significance in
both analyses were considered to be factors related to
S. aureus carriage.
Categorical variables were analyzed with chi-square tests
or Fisher’s exact test, as appropriate. Continuous variables
were analyzed with Student’s t-test or non-parametric tests.
Variables associated with MRSA carriage with a probability
equal to or less than 0.1 were further examined using
advanced multivariable logistic regression modelling. All
statistical tests were two-tailed, and p-values <0.05 were
considered to be significant. SPSS package version 12.0 was
used.
Approval for the study was obtained from the Research
Ethics Committee of the Hospital Universitari Bellvitge. No
written informed consent was obtained, because the study met
the criteria for a waiver of this requirement.
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RESULTS
Characteristics of patients
All residents present on the day of the study
(1377) were included in the analyses. Character-
istics of residents as ascribed by community
LTCFs are shown in Table 1. Among them,
71.4% were women; the mean age was 81.2 years
(SD 9.9 years). Underlying conditions were pres-
ent in 1138 (82.6%) residents. The most frequent
of these conditions were dementia in 548 (39.8%)
residents, diabetes mellitus in 321 (23.3%),
chronic obstructive pulmonary disease in 206
(15%), solid tumours in 194 (14.1%), and hemi-
plegia in 169 (12.3%). The median Charlson
index was 2 (interquartile range: 1–3) points,
and the mean Barthel index was 54.16 (SD 38.3)
points.
Prevalence of MRSA colonization
Cultures were performed from a total of 1377
nasal swabs and 82 decubitus ulcer swabs.
S. aureus carriage was observed in 33.5% of the
residents; 50.0% showed methicillin resistance.
Overall, 231 (16.8%) residents were colonized by
MRSA, 230 (16.7%) were colonized by MSSA, and
the remaining 916 (66.5%) were non-carriers. The
prevalence of MRSA colonization among resi-
dents was 16.8% (95% CI 14.9–18.8), varying
from 6.7% to 35.8% (p <0.001) among the LTCFs
(Table 1). MRSA was isolated from 213 (15.5%)
nasal swabs and from 49 (59.0%) decubitus
ulcers. Eighteen residents with decubitus ulcers
colonized by MRSA had a concomitant negative
nasal swab, and in 31 residents both sites were
colonized. Prior MRSA carriage was known in 77
(33.3% of the residents colonized by MRSA). No
MRSA infection was recorded during the cross-
sectional study.
Factors associated with S. aureus colonization in
community LTCF residents
Table 2 shows bivariate and multivariate analysis
comparing MRSA carriers with non-MRSA carri-
ers. MSSA carriers had a higher Charlson index,
more often had invasive devices, and more often
had been transferred from hospitals and resided
in facilities with <150 beds, as compared with
non-carriers (data not shown). Variables associ-
ated with MRSA colonization were age of
85 years or more, existence of decubitus ulcers,
previous antibiotic treatment, presence of inva-
sive devices, comorbidity, transfer from an
acute-care hospital, and residence in facilities
with <150 beds. Multivariate analysis to identify
independent factors associated with MSSA and
MRSA colonization are shown in Tables 3 and 4,
respectively. A comparison of the two models
showed that for MSSA carriers, a Charlson index
‡2 points and residence in a facility with <150
beds remained independent factors. On the other
hand, several independent variables were related
to MRSA colonization. It is noteworthy that
residents of a facility with <150 beds had at least
a two-fold higher probability of being MRSA
carriers (OR 2.10; 95% CI 1.52–2.92). Other mod-
ifiable factors were medical devices, presence of
decubitus ulcers, and previous antibiotic treat-
ment. Age of 85 years or more, a Charlson index
‡2 points and transfer from an acute-care hospital
were non-modifiable factors also related to MRSA
colonization.
Table 1. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) colonization and clinical characteristics of
residents in different community long-term-care facilities included in the study
Centres (number of beds)
1 (220) 2 (120) 3 (552) 4 (72) 5 (101) 6 (94) 7 (121) 8 (124) 9 (182) Total (1586)
Residents, n 195 115 466 72 95 89 109 73 163 1377
Male sex (%) 35.4 21.7 31.8 18.1 22.1 15.7 39.4 26.0 25.8 28.6
Mean age (years) 76.1 82.9 82.2 83.9 83.2 83.9 77.2 83.0 81.3 81.2
Charlson index ‡2% 73.1 47.0 35.2 47.2 67.4 58.0 70.4 40.3 66.7 52.8
Barthel index <30% 55.4 23.5 22.2 27.8 44.2 40.9 75.2 19.4 14.2 33.4
Decubitus ulcers (%) 12.3 6.1 5.8 2.8 8.4 8.0 30.2 1.4 1.8 8.1
Invasive devices use (%) 9.2 2.6 1.7 1.4 3.2 2.3 27.6 5.6 0 5.0
Prior antibiotic treatment (%) 29.7 22.6 10.3 12.5 23.2 18.2 44.0 40.8 36.2 22.5
Prior MRSA carriage (%) 21.8 1.7 1.3 6.9 6.3 0 2.8 0 8.0 5.6
Stay ‡6 months (%) 72.4 92.2 91.8 93.1 90.4 93.0 60.2 54.9 94.4 85.1
MSSA colonization (%) 16.9 8.7 24.3 16.7 15.8 24.7 29.4 27.4 11.8 16.7
MRSA colonization (%) 22.6 24.3 8.4 15.3 28.4 6.7 35.8 27.4 10.4 16.8
MSSA, methicillin-susceptible Staphylococcus aureus.
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DISCUSSION
In Europe, there is little information on the
prevalence of MRSA colonization among LTCF
residents. Recent studies have reported preva-
lences of 22% in the UK [7], 9.3% in Slovenia [8],
8.6% in Ireland [10] and 1.1% in Germany [9].
These figures are lower than those reported in
studies of Veterans’ Affairs facilities in the USA,
where the colonization rate can reach 45% [6,21].
To our knowledge, this is the first report on the
prevalence of MRSA colonization in community
LTCFs in Spain.
In a previous study, the clinical epidemiology
of patients with S. aureus bloodstream infections
upon hospital admission was analyzed, and the
major risk factors for methicillin resistance were
prior MRSA isolation and having been transferred
from an LTCF [14]. Given the increasing rate of
exchange of patients between facilities in the
healthcare setting and acute-care hospitals, it
seems pertinent to determine the magnitude of
MRSA colonization in LTCFs, as the extent of this
problem could influence the infection control
practices implemented by hospitals [22]. In Spain,
guidelines for the prevention of MRSA transmis-
sion in acute-care hospitals are well established
[23], even though there is a lack of such recom-
mendations for LTCFs. The policy of most facil-
ities is to admit MRSA carriers, although transfer
of these patients from acute-care centres is often
limited. This is because healthcare personnel have
not been instructed on the measures for handling
MRSA-colonized patients, and contact precaution
measures are costly.
We analyzed a large number of patients from a
homogeneous type of LTCF, i.e. community
LTCFs, and performed cultures from nasal swabs
and decubitus ulcers, which has been reported to
be a valid and efficient method for the detection of
MRSA carriage [24,25]. It is worthy of note that 18
residents in this study had decubitus ulcers
colonized by MRSA and a concomitant negative
nasal swab. No prior decolonization was recorded
in their medical records, and intestinal MRSA
carriage was not ruled out [26]. A high prevalence
of MRSA colonization was found among patients
within these institutions. This study allows an
appreciation with further detail of the MRSA
situation in the healthcare system. However, it is
important to emphasize that active surveillance
within LTCFs is not recommended in the absence
of surveillance of suspected outbreaks of infection;
thus, this study is not reproducible in daily clinical
practice. In LTCFs, clinical samples and medical
Table 2. Bivariate and multivariate















Sex (male) 72 (31.2) 322 (28.1) 1.15 (0.85–1.57)
Age ‡85 years 95 (41.3) 380 (33.4) 1.41 (1.05–1.88) 1.60 (1.16–2.21)
Charlson index ‡2 [17] 148 (64.6) 567 (50.4) 1.79 (1.33–2.41) 1.50 (1.09–2.08)
Barthel index <30 [18] 98 (43.0) 344 (31.4) 1.65 (1.23–2.21) 1.02 (0.72–1.43)
Decubitus ulcers 46 (20.1) 65 (5.7) 4.17 (2.77–6.28) 2.56 (1.58–4.17)
Previous antibiotic 97 (42.9) 207 (18.4) 3.33 (2.13–4.42) 2.44 (1.75–3.39)
Medical devices 31 (13.5) 37 (3.2) 4.67 (2.83–7.71) 2.47 (1.35–4.52)
Transferral from
acute-care centre
55 (24.1) 103 (9.4) 3.07 (2.13–4.42) 2.15 (1.39–3.31)
Stay ‡6 months 176 (77.9) 943 (86.6) 0.54 (0.38–0.78) 0.80 (0.53–1.22)
Centre with <150 beds 131 (56.7) 422 (36.8) 2.25 (1.69–2.99) 1.77 (1.29–2.41)
Comparison of patients colonized by MRSA with a control group of non-MRSA carriers.
Table 3. Associated factors for methicillin-susceptible
Staphylococcus aureus carriage vs. no S. aureus carriage
OR 95% CI p
Age ‡85 years 0.84 0.61–1.17 0.31
Charlson index ‡2 1.95 1.31–2.90 0.001
Barthel index <30 1.07 0.76–1.50 0.70
Decubitus ulcers 1.24 0.65–2.36 0.51
Previous antibiotic use 0.77 0.52–1.15 0.20
Medical devices 1.50 0.66–3.39 0.33
Transferral from acute-care centre 1.45 0.88–2.40 0.14
Stay ‡6 months 0.73 0.48–1.12 0.16
Centre with <150 beds 1.69 1.24–2.31 0.001
Logistic regression model.
Table 4. Associated factors for methicillin-resistant Staph-
ylococcus aureus carriage vs. no S. aureus carriage
OR 95% CI p
Age ‡85 years 1.56 1.13–2.19 0.009
Charlson index ‡2 2.36 1.57–3.55 <0.001
Barthel index <30 1.08 0.76–1.55 0.64
Decubitus ulcers 2.92 1.73–4.93 <0.001
Previous antibiotic 2.20 1.56–3.13 <0.001
Medical devices 3.05 1.56–5.97 0.001
Transferral from acute-care centre 2.52 1.59–4.02 <0.001
Stay ‡6 months 0.80 0.51–1.26 0.34
Centre with <150 beds 2.10 1.52–2.92 <0.001
Logistic regression model.
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records from hospitals should be considered, to
define the baseline rate of MRSA colonization
within a facility [21]. In the present study, approx-
imately one-third of the residents colonized by
MRSA were previously recognized as MRSA
carriers by the facility; this indicates irregular
application of the aforementioned recommenda-
tions. An outstanding finding is the wide variation
in the prevalence of MRSA colonization among
facilities, something that has been pointed out in
other reports [21]. Differences in colonization rates
may depend on several factors, such as the
prevalence of MRSA in the referral hospital and
infection control practices at the LTCF.
To determine factors associated with MRSA
colonization, two separate models using multi-
variate analysis were built. This is an effective
method for identifying factors associated with
resistant pathogens, particularly for studies on
infection control [20,27]. In this analysis, only the
size of facilities was considered as a specific factor
related to MRSA colonization; thus, it is difficult
to interpret the differences found in the preva-
lence of MRSA colonization among LTCFs. A
limitation of this point-prevalence study is the
absence of a second sample to confirm the
residents’ carrier status; consequently, it was not
possible to detect intermittent MRSA carriage. In
LTCFs, the rate of intermittent carriage of MRSA
is approximately 15% [26]. The study design
makes it difficult to determine the exact risk of
MRSA colonization; therefore, only associated
factors are referred to. Independent factors asso-
ciated with S. aureus carriage in community LTCF
residents were comorbidity and the size of the
facilities. Independent factors associated with
MRSA colonization among this population were
presence of decubitus ulcers, previous antibiotic
treatment, age of 85 years or more, use of invasive
devices, and transfer from an acute-care hospital.
Limited data are available concerning risk factors
for MRSA colonization in LTCFs in Europe.
Vovko et al. [28] found previous antibiotic treat-
ment and hospital admission to be risk factors in
an LTCF with a low number of MRSA carriers.
Interestingly, in other studies, care facility-specific
risk factors for MRSA colonization, e.g. low ratio
of nurses to beds, have been associated with
MRSA carriage [7,29]. In our model, there is no
variable that could explain why centres with <150
beds constitute an independent factor associated
with S. aureus colonization, but we have observed
that some of these facilities are deficient in
application of standard measures to limit cross-
transmission. A stay of more than 6 months in an
LTCF has been found to be associated with the
rate of MRSA colonization [29], in contrast to the
findings of other authors [9,10]. In the present
study, a stay of fewer than 6 months in an LTCF
was associated with MRSA colonization only in
the bivariate analysis; this should be interpreted
as a survival bias due to the study design.
These observations show that factors related to
methicillin resistance among residents in commu-
nity LTCFs are similar to those described in
hospitalized patients [30]. It is noteworthy that
modifiable factors could be prevented by the
introduction of only a few infection control
measures. Appropriate, individualized and easy-
to-implement infection control precautions, to-
gether with the promotion of a healthy lifestyle
for residents, should be observed in LTCFs. Hand
washing (alcohol-based gel) protocols, educational
programmes for healthcare personnel, guidelines
for antibiotic use and enhanced efforts to prevent
the development of decubitus ulcers would all be
suitable measures for community LTCFs.
To conclude, this study reports a large reservoir
of MRSA among community LTCFs in Spain. The
results indicate that restriction of referral of MRSA
carriers from acute-care hospitals to community
LTCFs would not be effective, because there is a
high prevalence of silent carriers. Patients trans-
ferred from LTCFs to hospitals should be consid-
ered at high risk for MRSA colonization and
should be included in a screening programme at
admission. We therefore recommend that control
strategies be coordinated between LTCFs and
acute-care hospitals. Further studies are necessary
to define the clinical impact of MRSA colonization
among residents in community LTCFs.
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